Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2026-05-19 @ 2:00 AM
Study NCT ID:
NCT00084435
Status:
WITHDRAWN
Last Update Posted:
2012-06-14
First Post:
2004-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage III squamous cell carcinoma of the lip and oral … | View |
| None | stage IV squamous cell carcinoma of the lip and oral … | View |
| None | stage III squamous cell carcinoma of the paranasal sinus and … | View |
| None | stage IV squamous cell carcinoma of the paranasal sinus and … | View |
| None | stage III salivary gland cancer | View |
| None | stage IV salivary gland cancer | View |
| None | stage III squamous cell carcinoma of the hypopharynx | View |
| None | stage IV squamous cell carcinoma of the hypopharynx | View |
| None | stage III squamous cell carcinoma of the larynx | View |
| None | stage IV squamous cell carcinoma of the larynx | View |
| None | stage III squamous cell carcinoma of the oropharynx | View |
| None | stage IV squamous cell carcinoma of the oropharynx | View |
| None | salivary gland squamous cell carcinoma | View |